Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

CHINA HEALTH GROUP INC.

中國醫療集團有限公司

(Carrying on business in Hong Kong as "萬全醫療集團")

(Incorporated in Cayman Islands with limited liability)

(Stock Code: 8225)

UPDATE ON PROPOSED TRANSFER OF LISTING

FROM GEM TO THE MAIN BOARD

Reference is made to the announcement of the Company dated 8 May 2020 (the "Announcement").Capitalized terms used in this announcement shall have the same meanings as those defined in the announcement.

Since the Company issued the Announcement in May 2020, the Board is pleased to announce that the Group is re-promoting the transfer of listing from GEM to the Main Board, making significant progress and submitting an application to the Stock Exchange as soon as possible. The Board considers that the listing of the Shares on the Main Board of the Stock Exchange will be beneficial to the future growth, financing flexibility, and business development of the Group.

As at the date of this announcement, no formal application has been made to the Stock Exchange in respect of the Transfer of Listing. Further announcements will be made by the Company to keep its shareholders and potential investors informed of the progress of the Possible Transfer of Listing as and when required under the Rules Governing the Listing of Securities on GEM of the Stock Exchange (the "GEM Listing Rules").

The Possible Transfer of Listing is subject to, among other things, the application to, and approval from, the Stock Exchange and may proceed this year. Potential investors and shareholders of the Company are advised to exercise caution when dealing in the securities of the Company.

1

By order of the Board

China Health Group Inc.

GUO Xia

Chairman

Hong Kong, 13 September 2021

As at the date hereof, the Board comprises two executive Directors, being Mr. GUO Xia and Dr. SONG Xuemei; one non-executive Director, being Mr. SU Yi; and three independent non-executive Directors, being Mr. QIU Rui, Dr. NI Binhui and Mr. ZHEN Ling. This announcement, for which the Directors collectively and individually accept full responsibility, includes particulars given in compliance with the GEM Listing Rules for the purpose of giving information with regard to the Company. The Directors, having made all reasonable enquiries, confirm that to the best of their knowledge and belief the information contained in this announcement is accurate and complete in all material respects and not misleading or deceptive, and there are no other matters the omission of which would make any statement herein or this announcement misleading. This announcement will remain on the website of The Stock Exchange of Hong Kong Limited at http://www.hkexnews.hk on the"Latest Listed Company Information"page for at least 7 days from the date of its posting and will be published on the Company' s website at http://www.chgi.net.

2

Attachments

  • Original document
  • Permalink

Disclaimer

China Health Group Inc. published this content on 13 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 September 2021 07:51:04 UTC.